In 2013, Tom founded Foxx Life Sciences, a bioprocess single-use technology supplier with over 5,000 products and five clean rooms in three manufacturing and distribution facilities in Salem and Londonderry, NH, and Hyderabad, India. Tom holds over 30 patents and dozens of registered trademarks, and previously served as president of Roush Life Sciences and Nypro Medical Products Group, the vice president at Millipore, and director of sales and marketing at Pall Corporation (Gelman Sciences). He serves on the board of the BIA, Medical Products Outsourcing, and was the 2009-11 chairman of Mass Medic, and was on the Advisory Board for Nypro Forbes India, Radius Product Development and NPA.
Brian Gottlob uses these words to describe the state’s current economic climate: “Uncertainty rules.” The director of the New Hampshire Employment Security's Economic and Labor Market Information Bureau raised several issues — from immigration and unemployment, to housing prices and consumer spending — as reasons for both hope and concern for the economy into 2026.
Bank of NH senior wealth management officer Bob Magan speaks on community initiatives, fiscal responsibility and more in this week's episode of Down to Business
A 2024 Human Interest study found 91% of employees with access to financial wellness education enrolled in their workplace retirement plan, compared to just 76% enrollment without it.
The inflatable treat violates a town ordinance in Westmoreland
NH’s 2025 energy laws shift focus to nuclear, natural gas, and clean energy while pausing offshore wind and exploring grid independence.
In her new book, “The Emotionally Intelligent Team,” published by Harvard Business Review Press, Druskat explores the overlooked factor she says separates high-performing teams from the rest: emotional intelligence.
I am alarmed by the growing erosion of trust in science-based health guidance.
So far this year, the unemployment rate is ticking up, reaching 3% in February and 3.1% in March through July, and dipping slightly back to 3% in August
Investors should be asking their financial advisors crucial questions at various points in time.
